Common Herbal Dietary Supplement-Drug Interactions.

Nearly 25% of U.S. adults report concurrently taking a prescription medication with a dietary supplement. Some supplements, such as St. John's wort and goldenseal, are known to cause clinically important drug interactions and should be avoided by most patients receiving any pharmacologic therapy. However, many other supplements are predicted to cause interactions based only on in vitro studies that have not been confirmed or have been refuted in human clinical trials. Some supplements may cause interactions with a few medications but are likely to be safe with other medications (e.g., curcumin, echinacea, garlic, Asian ginseng, green tea extract, kava kava). Some supplements have a low likelihood of drug interactions and, with certain caveats, can safely be taken with most medications (e.g., black cohosh, cranberry, ginkgo, milk thistle, American ginseng, saw palmetto, valerian). Clinicians should consult reliable dietary supplement resources, or clinical pharmacists or pharmacologists, to help assess the safety of specific herbal supplement-drug combinations. Because most patients do not disclose supplement use to clinicians, the most important strategy for detecting herb-drug interactions is to develop a trusting relationship that encourages patients to discuss their dietary supplement use.

[1]  J. Werba,et al.  The effect of green tea on simvastatin tolerability. , 2008, Annals of internal medicine.

[2]  K. Rentsch,et al.  Garlic extract induces intestinal P-glycoprotein, but exhibits no effect on intestinal and hepatic CYP3A4 in humans. , 2010, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[3]  Bruce E. Bray,et al.  Ginkgo and Warfarin Interaction in a Large Veterans Administration Population , 2015, AMIA.

[4]  C. Flexner,et al.  Pharmacokinetic and metabolic effects of American ginseng (Panax quinquefolius) in healthy volunteers receiving the HIV protease inhibitor indinavir , 2008, BMC complementary and alternative medicine.

[5]  D. K. Williams,et al.  Effect of Goldenseal (Hydrastis canadensis) and Kava Kava (Piper methysticum) Supplementation on Digoxin Pharmacokinetics in Humans , 2007, Drug Metabolism and Disposition.

[6]  Bill Gurley,et al.  Assessing the Clinical Significance of Botanical Supplementation on Human Cytochrome P450 3A Activity: Comparison of a Milk Thistle and Black Cohosh Product to Rifampin and Clarithromycin , 2006, Journal of clinical pharmacology.

[7]  G. Anderson,et al.  Drug Interaction Potential of Soy Extract and Panax Ginseng , 2003, Journal of clinical pharmacology.

[8]  D. K. Williams,et al.  EFFECT OF MILK THISTLE (SILYBUM MARIANUM) AND BLACK COHOSH (CIMICIFUGA RACEMOSA) SUPPLEMENTATION ON DIGOXIN PHARMACOKINETICS IN HUMANS , 2006, Drug Metabolism and Disposition.

[9]  J. Kovacs,et al.  Influence of Panax ginseng on Cytochrome P450 (CYP)3A and P‐glycoprotein (P‐gp) Activity in Healthy Participants , 2012, Journal of clinical pharmacology.

[10]  A. Mitchell,et al.  Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. , 2002, JAMA.

[11]  P. Neuvonen,et al.  Effects of daily ingestion of cranberry juice on the pharmacokinetics of warfarin, tizanidine, and midazolam--probes of CYP2C9, CYP1A2, and CYP3A4. , 2007, Clinical pharmacology and therapeutics.

[12]  S. Misaka,et al.  Inhibitory Effects of Green Tea and (–)-Epigallocatechin Gallate on Transport by OATP1B1, OATP1B3, OCT1, OCT2, MATE1, MATE2-K and P-Glycoprotein , 2015, PloS one.

[13]  A. Shaughnessy,et al.  Herbal and dietary supplement--drug interactions in patients with chronic illnesses. , 2008, American family physician.

[14]  J. Falloon,et al.  The effect of garlic supplements on the pharmacokinetics of saquinavir. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  D. K. Williams,et al.  Gauging the clinical significance of P-glycoprotein-mediated herb-drug interactions: comparative effects of St. John's wort, Echinacea, clarithromycin, and rifampin on digoxin pharmacokinetics. , 2008, Molecular nutrition & food research.

[16]  R. Hoerr,et al.  Effect of Ginkgo biloba special extract EGb 761® on human cytochrome P450 activity: a cocktail interaction study in healthy volunteers , 2011, European Journal of Clinical Pharmacology.

[17]  R. Ballard-Barbash,et al.  Dietary supplement use in individuals living with cancer and other chronic conditions: a population-based study. , 2008, Journal of the American Dietetic Association.

[18]  D. Greenblatt,et al.  Effect of a herbal extract containing curcumin and piperine on midazolam, flurbiprofen and paracetamol (acetaminophen) pharmacokinetics in healthy volunteers , 2013, British journal of clinical pharmacology.

[19]  K. Maeda,et al.  Pharmacokinetic interaction study of sulphasalazine in healthy subjects and the impact of curcumin as an in vivo inhibitor of BCRP , 2012, British journal of pharmacology.

[20]  R. Day,et al.  Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. , 2004, British journal of clinical pharmacology.

[21]  I. Khan,et al.  In Vivo Effects of Goldenseal, Kava Kava, Black Cohosh, and Valerian on Human Cytochrome P450 1A2, 2D6, 2E1, and 3A4/5 Phenotypes , 2005, Clinical pharmacology and therapeutics.

[22]  Y. Sawada,et al.  EFFECTS OF HERBAL EXTRACTS ON THE FUNCTION OF HUMAN ORGANIC ANION-TRANSPORTING POLYPEPTIDE OATP-B , 2006, Drug Metabolism And Disposition.

[23]  P. Barnes,et al.  Complementary and alternative medicine use among adults and children: United States, 2007. , 2008, National health statistics reports.

[24]  J. Donovan,et al.  GREEN TEA (CAMELLIA SINENSIS) EXTRACT DOES NOT ALTER CYTOCHROME P450 3A4 OR 2D6 ACTIVITY IN HEALTHY VOLUNTEERS , 2004, Drug Metabolism and Disposition.

[25]  P. Barnes,et al.  Trends in the use of complementary health approaches among adults: United States, 2002-2012. , 2015, National health statistics reports.

[26]  S. Gardner,et al.  Clinical Assessment of Effects of Botanical Supplementation on Cytochrome P450 Phenotypes in the Elderly , 2005, Drugs & aging.

[27]  Shiew-Mei Huang,et al.  The Effect of Echinacea (Echinacea purpurea Root) on Cytochrome P450 Activity in Vivo , 2004, Clinical pharmacology and therapeutics.

[28]  Nima M. Patel,et al.  Possible Increase in Liver Enzymes Secondary to Atorvastatin and Black Cohosh Administration , 2007 .

[29]  M. Schwab,et al.  Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. , 2013, Pharmacology & therapeutics.

[30]  Honghao Zhou,et al.  Effect of silymarin on the pharmacokinetics of losartan and its active metabolite E-3174 in healthy Chinese volunteers , 2009, European Journal of Clinical Pharmacology.

[31]  J. Donovan,et al.  Multiple doses of saw palmetto (Serenoa repens) did not alter cytochrome P450 2D6 and 3A4 activity in normal volunteers , 2003, Clinical pharmacology and therapeutics.

[32]  D. K. Williams,et al.  Supplementation With Goldenseal (Hydrastis canadensis), but not Kava Kava (Piper methysticum), Inhibits Human CYP3A Activity In Vivo , 2008, Clinical pharmacology and therapeutics.

[33]  I. Khan,et al.  In vivo assessment of botanical supplementation on human cytochrome P450 phenotypes: Citrus aurantium, Echinacea purpurea, milk thistle, and saw palmetto , 2004, Clinical pharmacology and therapeutics.

[34]  Honghao Zhou,et al.  Plant Polyphenol Curcumin Significantly Affects CYPIA2 and CYP2A6 Activity in Healthy, Male Chinese Volunteers , 2010, The Annals of pharmacotherapy.

[35]  A. Burstein,et al.  St John's Wort: Effect on CYP3A4 activity , 2000 .

[36]  J. Markowitz,et al.  The Effects of Milk Thistle (Silybum marianum) on Human Cytochrome P450 Activity , 2014, Drug Metabolism and Disposition.

[37]  L. Dey,et al.  American ginseng reduces warfarin’s effect in healthy patients: A randomized, controlled trial☆ , 2004 .

[38]  A. Etheridge,et al.  Inhibition of human cytochrome P450 activities by kava extract and kavalactones. , 2002, Drug metabolism and disposition: the biological fate of chemicals.

[39]  Honghao Zhou,et al.  St John's wort induces both cytochrome P450 3A4–catalyzed sulfoxidation and 2C19–dependent hydroxylation of omeprazole , 2004, Clinical pharmacology and therapeutics.

[40]  S. Misaka,et al.  Green Tea Ingestion Greatly Reduces Plasma Concentrations of Nadolol in Healthy Subjects , 2014, Clinical pharmacology and therapeutics.

[41]  D. Carrier,et al.  Clinical assessment of CYP2D6-mediated herb-drug interactions in humans: effects of milk thistle, black cohosh, goldenseal, kava kava, St. John's wort, and Echinacea. , 2008, Molecular nutrition & food research.

[42]  J. Donovan,et al.  MULTIPLE NIGHT-TIME DOSES OF VALERIAN (Valeriana officinalis) HAD MINIMAL EFFECTS ON CYP3A4 ACTIVITY AND NO EFFECT ON CYP2D6 ACTIVITY IN HEALTHY VOLUNTEERS , 2004, Drug Metabolism and Disposition.

[43]  C. Flexner,et al.  Possible Differential Induction of Phase 2 Enzyme and Antioxidant Pathways by American Ginseng, Panax quinquefolius , 2008, Journal of clinical pharmacology.

[44]  B. Crabtree,et al.  ’They Don’t Ask Me So I Don’t Tell Them’: Patient-Clinician Communication About Traditional, Complementary, and Alternative Medicine , 2009, The Annals of Family Medicine.

[45]  M. Ford,et al.  Effect of high-dose cranberry juice on the pharmacodynamics of warfarin in patients. , 2010, British journal of clinical pharmacology.

[46]  R. Day,et al.  Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. , 2005, British journal of clinical pharmacology.